Pregled bibliografske jedinice broj: 1252604
Recurrent hyperkalaemia management and use of renin–angiotensin–aldosterone system inhibitors: a European multi-national targeted chart review
Recurrent hyperkalaemia management and use of renin–angiotensin–aldosterone system inhibitors: a European multi-national targeted chart review // Clinical Kidney Journal, 13 (2020), 4; 714-719 doi:10.1093/ckj/sfz129 (međunarodna recenzija, pismo uredniku, znanstveni)
CROSBI ID: 1252604 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Recurrent hyperkalaemia management and use of
renin–angiotensin–aldosterone system inhibitors: a
European multi-national targeted chart review
Autori
Rossignol, Patrick ; Ruilope, Luis M ; Cupisti, Adamasco ; Ketteler, Markus ; Wheeler, David C ; Pignot, Marc ; Cornea, Georgiana ; Schulmann, Thierry ; Lund, Lars H
Izvornik
Clinical Kidney Journal (2048-8513) 13
(2020), 4;
714-719
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo uredniku, znanstveni
Ključne riječi
HEART FAILURE ; KIDNEY DISEASE ; POTASSIUM ; MORTALITY
Sažetak
Hyperkalaemia often occurs due to impaired excretion of potassium in patients with chronic kidney disease and other chronic conditions such as heart failure and/or diabetes mellitus.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
